Delivery Order SPE2DB20D3104-SPE2DB22FV3T8
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ESOMEPRAZOLE MAG DR 40 MG CAP 90S. The $16,646.74 firm fixed-price delivery order contract has a completion date of June 27, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,925.62 firm fixed-price delivery order is for the supply of 4558923068 - ESOMEPRAZOLE MAG DR 20 MG CAP 90S, with an ultimate completion date of October 31, 2022. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, SPE2DB20D1004|SPE2DB22FF5V7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company. The $1,360.78 firm-fixed-price delivery order is for the supply of 4557045057 - ESOMEPRAZOLE MAG DR 20 MG CAP 30S. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as a...
- This federal contract award, with an ID of SPE2DB20D2104|SPE2DB23FQ76Z, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,826.69 Delivery Order is for the supply of 4558809522 - ESOMEPRAZOLE MAG DR 20 MG CAP 90S, with an ultimate completion date of October 19, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
- The federal contract award is for the delivery of Esomeprazole Magnesium delayed-release capsules, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract has a ceiling value of $1,860.66 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,902.86 firm fixed price delivery order is for 4560879515 ESOMEPRAZOLE MAG DR 20 MG CAP 1000S, with a completion date of May 10, 2023. The contract is not set aside and is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which provides a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $2,061.12, is for the supply of ESOMEPRAZOLE MAG DR 40 MG CAP 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of August 30, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S....
- This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of ESOMEPRAZOLE MAG DR 20 MG CAP 90S. The award has a ceiling value of $1,411.61 and a completion date of July 2, 2025. The contract is funded by the Defense Logistics Agency (DLA), a defense agency, and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, identified as SPE2DX15D7067|SPE2DX24F2ZLC, is for the supply of ESOMEPRAZOLE MAG DR 20 MG CAP 90S, a generic medication. The contract has a ceiling value of $27,793.11 and a completion date of June 12, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen holds a...
- This federal contract award is for the delivery of Esomeprazole Magnesium Delayed-Release capsules, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $1,696.24. The contract is a delivery order with a firm fixed price type and has an ultimate completion date of February 28, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB22FV3T8Delivery Order
This federal contract award, SPE2DB20D3104|SPE2DB22FV3T8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,010.06 firm fixed-price delivery order is for the supply of 4555509454 - ESOMEPRAZOLE MAG DR 40 MG CAP 30S, with a period of performance ending on November 24, 2021. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical products, including specialty medications, generic drugs, and medical devices, to support military and veteran healthcare programs. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for delivering essential pharmaceutical and medical supplies to the Department of Defense globally. Additionally, Amerisourcebergen maintains a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 11/23/21 |